Literature DB >> 11142774

Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype.

M Friedrich1, S Krammig, M Henze, W D Döcke, W Sterry, K Asadullah.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11142774     DOI： 10.1007/s004030000167

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  22 in total

1.  Expression of Bcl-2 family proteins in psoriasis.

Authors:  Tanja Batinac; Gordana Zamolo; Ita Hadzisejdić; Gordana Zauhar; Gordana Brumini; Alen Ruzić; Viktor Persić
Journal:  Croat Med J       Date:  2007-06       Impact factor: 1.351

2.  Pharmacokinetics, biologic activity, and tolerability of alefacept by intravenous and intramuscular administration.

Authors:  Ashay K Vaishnaw; Christopher N TenHoor
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-12       Impact factor: 2.745

3.  Predominance of activated, clonally expanded T helper type 17 cells within the CD4+ T cell population in psoriatic lesions.

Authors:  B J Lewis; S Rajpara; A M Haggart; H M Wilson; R N Barker; A D Ormerod
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 4.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

5.  Voltage-gated potassium channel Kv1.3 blocker as a potential treatment for rat anti-glomerular basement membrane glomerulonephritis.

Authors:  Toshitake Hyodo; Takashi Oda; Yuichi Kikuchi; Keishi Higashi; Taketoshi Kushiyama; Kojiro Yamamoto; Muneharu Yamada; Shigenobu Suzuki; Ryota Hokari; Manabu Kinoshita; Shuhji Seki; Hidehiko Fujinaka; Tadashi Yamamoto; Soichiro Miura; Hiroo Kumagai
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

Review 6.  New insights of T cells in the pathogenesis of psoriasis.

Authors:  Yihua Cai; Chris Fleming; Jun Yan
Journal:  Cell Mol Immunol       Date:  2012-06-18       Impact factor: 11.530

Review 7.  Psoriatic arthritis in Africa.

Authors:  Ajesh B Maharaj; Adewale Adebajo
Journal:  Clin Rheumatol       Date:  2021-06-28       Impact factor: 2.980

8.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.

Authors:  Heike Wulff; Peter A Calabresi; Rameeza Allie; Sung Yun; Michael Pennington; Christine Beeton; K George Chandy
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis--xenograft model.

Authors:  Smriti Kundu-Raychaudhuri; Yi-Je Chen; Heike Wulff; Siba P Raychaudhuri
Journal:  J Autoimmun       Date:  2014-08-28       Impact factor: 7.094

Review 10.  Psoriasis.

Authors:  Paola Di Meglio; Federica Villanova; Frank O Nestle
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-01       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.